vs

Side-by-side financial comparison of Copart (CPRT) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.2× Copart). Copart runs the higher net margin — 35.0% vs 27.6%, a 7.4% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 0.7%). Over the past eight quarters, ResMed's revenue compounded faster (7.8% CAGR vs 6.4%).

Copart, Inc. is a multinational provider of online vehicle auction and remarketing services to automotive resellers such as insurance, rental car, fleet, and finance companies in 11 countries: the US, Canada, the UK, Germany, Ireland, Brazil, Spain, UAE, Bahrain, Oman, and Finland. Headquartered in Dallas, Texas, Copart has more than 200 physical locations, where it houses more than 10,000 acres of vehicle inventory.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

CPRT vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.2× larger
RMD
$1.4B
$1.2B
CPRT
Growing faster (revenue YoY)
RMD
RMD
+10.3% gap
RMD
11.0%
0.7%
CPRT
Higher net margin
CPRT
CPRT
7.4% more per $
CPRT
35.0%
27.6%
RMD
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.8%
6.4%
CPRT

Income Statement — Q1 FY2026 vs Q4 FY2026

Metric
CPRT
CPRT
RMD
RMD
Revenue
$1.2B
$1.4B
Net Profit
$403.7M
$392.6M
Gross Margin
61.8%
Operating Margin
37.3%
34.6%
Net Margin
35.0%
27.6%
Revenue YoY
0.7%
11.0%
Net Profit YoY
11.5%
13.9%
EPS (diluted)
$0.41
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPRT
CPRT
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$1.2B
$1.4B
Q3 25
$1.1B
$1.3B
Q2 25
$1.2B
$1.3B
Q1 25
$1.2B
$1.3B
Q4 24
$1.1B
$1.3B
Q3 24
$1.1B
$1.2B
Net Profit
CPRT
CPRT
RMD
RMD
Q2 26
$392.6M
Q1 26
$398.7M
Q4 25
$403.7M
$392.6M
Q3 25
$396.4M
$348.5M
Q2 25
$406.6M
$379.7M
Q1 25
$387.4M
$365.0M
Q4 24
$362.1M
$344.6M
Q3 24
$322.6M
$311.4M
Gross Margin
CPRT
CPRT
RMD
RMD
Q2 26
61.8%
Q1 26
62.2%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Operating Margin
CPRT
CPRT
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
37.3%
34.6%
Q3 25
36.7%
33.4%
Q2 25
37.3%
33.7%
Q1 25
36.6%
33.0%
Q4 24
35.4%
32.5%
Q3 24
33.6%
31.6%
Net Margin
CPRT
CPRT
RMD
RMD
Q2 26
27.6%
Q1 26
27.9%
Q4 25
35.0%
27.6%
Q3 25
35.2%
26.1%
Q2 25
33.6%
28.2%
Q1 25
33.3%
28.3%
Q4 24
31.6%
26.9%
Q3 24
30.2%
25.4%
EPS (diluted)
CPRT
CPRT
RMD
RMD
Q2 26
$2.68
Q1 26
$2.74
Q4 25
$0.41
$2.68
Q3 25
$0.40
$2.37
Q2 25
$0.42
$2.58
Q1 25
$0.40
$2.48
Q4 24
$0.37
$2.34
Q3 24
$0.34
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPRT
CPRT
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$9.6B
$6.3B
Total Assets
$10.6B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPRT
CPRT
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.7B
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.2B
Q1 25
$932.7M
Q4 24
$521.9M
Q3 24
$426.4M
Total Debt
CPRT
CPRT
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
Q3 24
$0
$667.6M
Stockholders' Equity
CPRT
CPRT
RMD
RMD
Q2 26
$6.3B
Q1 26
$6.5B
Q4 25
$9.6B
$6.3B
Q3 25
$9.2B
$6.1B
Q2 25
$8.8B
$6.0B
Q1 25
$8.3B
$5.5B
Q4 24
$7.9B
$5.3B
Q3 24
$7.5B
$5.2B
Total Assets
CPRT
CPRT
RMD
RMD
Q2 26
$8.5B
Q1 26
$8.8B
Q4 25
$10.6B
$8.5B
Q3 25
$10.1B
$8.3B
Q2 25
$9.7B
$8.2B
Q1 25
$9.2B
$7.6B
Q4 24
$8.9B
$7.1B
Q3 24
$8.4B
$7.2B
Debt / Equity
CPRT
CPRT
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.00×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPRT
CPRT
RMD
RMD
Operating Cash FlowLast quarter
$535.3M
Free Cash FlowOCF − Capex
$427.2M
FCF MarginFCF / Revenue
37.0%
Capex IntensityCapex / Revenue
9.4%
Cash ConversionOCF / Net Profit
1.33×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPRT
CPRT
RMD
RMD
Q2 26
Q1 26
Q4 25
$535.3M
$339.7M
Q3 25
$438.5M
$457.3M
Q2 25
$700.9M
$538.8M
Q1 25
$178.1M
$578.7M
Q4 24
$482.3M
$308.6M
Q3 24
$439.2M
$325.5M
Free Cash Flow
CPRT
CPRT
RMD
RMD
Q2 26
Q1 26
Q4 25
$427.2M
$311.2M
Q3 25
$350.8M
$414.4M
Q2 25
$572.9M
$508.2M
Q1 25
$61.5M
$557.9M
Q4 24
$245.5M
$288.0M
Q3 24
$301.3M
$307.7M
FCF Margin
CPRT
CPRT
RMD
RMD
Q2 26
Q1 26
Q4 25
37.0%
21.9%
Q3 25
31.2%
31.0%
Q2 25
47.3%
37.7%
Q1 25
5.3%
43.2%
Q4 24
21.4%
22.5%
Q3 24
28.2%
25.1%
Capex Intensity
CPRT
CPRT
RMD
RMD
Q2 26
Q1 26
Q4 25
9.4%
2.0%
Q3 25
7.8%
3.2%
Q2 25
10.6%
2.3%
Q1 25
10.0%
1.6%
Q4 24
20.6%
1.6%
Q3 24
12.9%
1.5%
Cash Conversion
CPRT
CPRT
RMD
RMD
Q2 26
Q1 26
Q4 25
1.33×
0.87×
Q3 25
1.11×
1.31×
Q2 25
1.72×
1.42×
Q1 25
0.46×
1.59×
Q4 24
1.33×
0.90×
Q3 24
1.36×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPRT
CPRT

Services$952.1M82%
Other$203.0M18%

RMD
RMD

Segment breakdown not available.

Related Comparisons